What is the recommended treatment for an acute attack of migraine in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Migraine Attacks in Children

For acute migraine attacks in children, ibuprofen is the first-line treatment, while adolescents may also benefit from triptans such as sumatriptan nasal spray. 1

First-Line Treatment Options

  • Ibuprofen (10 mg/kg) is recommended as the first-line medication for treating pain in both children and adolescents with acute migraine attacks 1, 2
  • Acetaminophen (15 mg/kg) is an alternative first-line option, though it may be less effective than ibuprofen 2
  • Treatment should be administered early in the migraine attack for maximum effectiveness 1
  • For mild attacks in young children, bed rest alone might be sufficient in some cases 1

Second-Line Treatment Options for Adolescents

  • For adolescents with moderate to severe attacks or those who don't respond to NSAIDs, consider the following options:
    • Sumatriptan/naproxen oral combination 1
    • Zolmitriptan nasal spray 1
    • Sumatriptan nasal spray 1, 2
    • Rizatriptan orally disintegrating tablets (ODT) 1
    • Almotriptan oral 1

Special Clinical Situations

  • For rapidly escalating headache pain, consider non-oral triptan formulations (nasal sprays) 1
  • For attacks with significant nausea or vomiting:
    • Use non-oral triptan formulations 1
    • Add an antiemetic medication 1
    • For adolescents aged 12-17 years, domperidone can be used for nausea 1

Treatment Failure Management

  • If one triptan is ineffective, try another triptan or a NSAID-triptan combination 1
  • For severe, refractory attacks, dihydroergotamine mesylate may be considered (20-40 μg/kg orally or maximum 1 mg/day intravenously), though evidence is limited 2

Important Considerations and Cautions

  • Counsel patients and families to treat migraine attacks early for best results 1
  • Advise on lifestyle factors and migraine triggers that should be avoided 1
  • Warn about medication overuse, which can occur with frequent use of acute medications (≥15 days/month with NSAIDs or ≥10 days/month with triptans) 3, 4
  • Avoid opioids and barbiturates due to questionable efficacy, adverse effects, and risk of dependency 3, 5
  • The evidence base for medication therapy in children is complicated by high placebo response rates in clinical trials 1
  • Nasal spray formulations of triptans appear to be most effective in adolescents 1

When to Consider Preventive Treatment

  • Consider preventive treatments in children and adolescents with:
    • Frequent headaches 1
    • Disabling headaches 1
    • Medication overuse 1
  • Discuss with patients and families that in many trials, placebo was as effective as the studied preventive medications 1
  • Options for prevention include amitriptyline (especially when combined with cognitive behavioral therapy), topiramate, and propranolol 1, 6

By following this algorithmic approach to treating acute migraine attacks in children, clinicians can help reduce symptoms, disability, and improve quality of life for these young patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Pharmacologic treatment of acute migraine attack in children].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005

Guideline

Dexamethasone in Migraine Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Migraine Treatment Options Without Opiates or Diphenhydramine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Options for Unilateral Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.